Skip to main contentSkip to navigation
Sirius Investors
Alseres Pharmaceuticals, Inc.

Alseres Pharmaceuticals, Inc.

ALSE
OTCHealthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for ALSE. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
719.92K
-42.20% over period
CAGR: -1.94%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
8.43M
N/A over period

Market Cap History

Investor Valuation Insights

As of Jun 30, 2014

EV/EBITDA

Distorted

-29.53x

Negative EV/EBITDA usually means negative EBITDA; compare with revenue and cash flow metrics.

EV vs Market Cap Spread

7.71M

EV is +1070.4% vs equity value

Capital Structure Signal

Net Debt Profile

EV premium trend: +1174.8 pp vs earliest data

Additional Multiples

EV/Sales: 508.07x

Net Debt/EBITDA: -26.39x

Share count change in dataset: +11460.38%

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Dec 31, 2013719.92K8.43M$117.506.13K
Dec 31, 2012490.16K6.88M$80.006.13K
Dec 31, 20111.42M29.01M$240.005.92K
Dec 31, 2010
Dec 31, 2009
Dec 31, 2008
Dec 31, 2007
Dec 31, 2006
Dec 31, 2005
Dec 31, 2004
Dec 31, 2003
Dec 31, 2002
Dec 31, 2001
Dec 31, 2000
Dec 31, 1999
Dec 31, 1998
Dec 31, 1997
Dec 31, 1996
Dec 31, 1995
Dec 31, 1994
Dec 31, 1993
Dec 31, 1992
Dec 31, 1991
Dec 31, 1990
Dec 31, 1989
Dec 31, 1988
Dec 31, 1987
Dec 31, 1986
Dec 31, 1985

Enterprise Value Analysis

Price Change (Dec 2012 to Dec 2013)

The stock price has increased from Dec 2012 to Dec 2013.
+46.88%

Recent Volatility

The stock price has been relatively volatile over the last 5 periods, indicating a higher risk profile.
0.45

Risk-Adjusted Return

The stock's returns do not compensate for its risk level, suggesting a poor risk-reward profile.
-0.66

Market Cap Change (Dec 2012 to Dec 2013)

The company's market capitalization has increased from Dec 2012 to Dec 2013.
+46.88%

Enterprise Value Change (Dec 2012 to Dec 2013)

The company's enterprise value has increased from Dec 2012 to Dec 2013, suggesting growth in the company's total economic value.
+22.41%

Market Cap vs. Enterprise Value

A lower enterprise value growth rate compared to market cap growth could suggest that the company is reducing debt or increasing cash reserves.
Market Cap Growth > EV Growth

Market Cap CAGR

The Compound Annual Growth Rate (CAGR) of market capitalization represents the mean annual growth rate over the entire available history (29 periods), accounting for compounding effects.
-1.94%